Tyra Biosciences, Inc. (TYRA)
TYRA Stock Price Chart
Explore Tyra Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze TYRA price movements and trends.
TYRA Company Profile
Discover essential business fundamentals and corporate details for Tyra Biosciences, Inc. (TYRA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Sept 2021
Employees
60.00
Website
https://www.tyra.bioCEO
Todd Harris
Description
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.
TYRA Financial Timeline
Browse a chronological timeline of Tyra Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.67.
Earnings released on 13 May 2026
EPS came in at -$0.64 falling short of the estimated -$0.60 by -6.67%.
Earnings released on 2 Mar 2026
EPS came in at -$0.57 falling short of the estimated -$0.54 by -5.56%.
Earnings released on 5 Nov 2025
EPS came in at -$0.50 matching the estimated -$0.50.
Earnings released on 14 Aug 2025
EPS came in at -$0.47 surpassing the estimated -$0.53 by +11.32%.
Earnings released on 8 May 2025
EPS came in at -$0.47 surpassing the estimated -$0.49 by +4.08%.
Earnings released on 27 Mar 2025
EPS came in at -$0.43 surpassing the estimated -$0.48 by +10.42%.
Earnings released on 7 Nov 2024
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%.
Earnings released on 7 Aug 2024
EPS came in at -$0.32 surpassing the estimated -$0.41 by +21.95%.
Earnings released on 9 May 2024
EPS came in at -$0.35 surpassing the estimated -$0.46 by +23.91%.
Earnings released on 19 Mar 2024
EPS came in at -$0.53 falling short of the estimated -$0.48 by -10.42%, while revenue for the quarter reached $502.00k .
Earnings released on 7 Nov 2023
EPS came in at -$0.49 falling short of the estimated -$0.35 by -40.00%.
Earnings released on 10 Aug 2023
EPS came in at -$0.31 surpassing the estimated -$0.34 by +8.82%.
Earnings released on 4 May 2023
EPS came in at -$0.28 surpassing the estimated -$0.37 by +24.32%.
Earnings released on 22 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.35 by +11.43%.
Earnings released on 3 Nov 2022
EPS came in at -$0.30 surpassing the estimated -$0.41 by +26.83%.
Earnings released on 4 Aug 2022
EPS came in at -$0.36 falling short of the estimated -$0.33 by -9.09%.
Earnings released on 5 May 2022
EPS came in at -$0.36 falling short of the estimated -$0.20 by -80.00%.
Earnings released on 3 Mar 2022
EPS came in at -$0.24 falling short of the estimated -$0.21 by -14.29%.
Earnings released on 3 Nov 2021
EPS came in at -$0.72 falling short of the estimated -$0.29 by -148.28%.
Earnings released on 15 Sept 2021
EPS came in at -$0.19 .
TYRA Stock Performance
Access detailed TYRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
